Description

Standard & Poor's Global Industry Surveys help meet the growing demand for in-depth industry analysis from a European, Asian and Latin American perspective. Designed for strategic planners, management consultants, money managers, researchers, business students, and academic faculty, Global Industry Surveys are an excellent way to get up to speed on current events, future trends and the competitive dynamics of leading industries outside of North America. Intended to complement a subscription to Standard & Poor's flagship industry research product - Industry Surveys - each Global Industry Survey will include the following sections: Current Environment, Industry Trends, How the Industry Operates, Key Industry Ratios and Statistics, Glossary, Industry References and Comparative Company Analysis.

Table of Contents

CURRENT ENVIRONMENT European pharmaceutical companies flourish 2006 was a good year for European pharma New product outlook for 2007 Mergers and acquisitions continue to reshape European pharma Uncertainty over safety and pricing in the US 2007 is another big year for generics INDUSTRY PROFILE Europe remains a geographic cornerstone Significant role in global production National markets INDUSTRY TRENDS European pharma strives for more innovation Turning to biotechnology for new products Europe is aging and shrinking Cost cutting continues Turning to OTC for savings Difficult environment prompts new strategies HOW THE INDUSTRY OPERATES Developing drugs Drug patents protect intellectual property Coordinated system speeds approvals Pharmaceutical pricing and use policies vary in Europe KEY INDUSTRY RATIOS AND STATISTICS GLOSSARY INDUSTRY REFERENCES COMPARATIVE COMPANY ANALYSIS